GULLESTAD MEDISINSKE HOLDING AS
Operating
Investering i finansielle aktiva.
Organization
- CEO
- LK
- Chairman of the board
- LK
- Years since formation
- 12 years
- since Sep 3, 2014
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 30
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 9,716,547
- NOK
- Annual total result 2025
- 5,451,000
- NOK
- Total equity 2025
- 5,481,000
- NOK
Last update: Feb 26, 2026
Locations
- Company addressBorgenveien 29B 0370 OSLO, Norge
Copied!
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
LK | Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
LK | Chairman | 100 % directly |
Others
| Name | Role | Shares |
|---|---|---|
V VIDI REVISJON AS | Auditor | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
LK | Managing Director/CEO, Chairman | 100 % directly |
Last update: Dec 27, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
LK | Ordinary shares | 30 | 100 % |
Shares owned by the GULLESTAD MEDISINSKE HOLDING AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
C COLOSSEUMKLINIKKEN MEDISINSKE SENTER AS | Ordinary shares | 51,000 | 50 % |
F FEELIX AS | Ordinary shares | 15,000 | 50 % |
C COLOSSEUMKLINIKKEN ALLMENNSEKSJONEN AS | Ordinary shares | 99 | 49.5 % |
M MEDPOINT AS Closed | Ordinary shares | 20,000 | 25 % |
A AMBASSADEN FYSIKALSKE AS | Ordinary shares | 15 | 15 % |
E EYR MEDICAL AS | Class B shares | 33,115 | 4.42 % |
H HOUSE OF MATH AS Closed | NO0012423542 | 1,200 | < 0.01 % |
N NYKODE THERAPEUTICS ASA | NO0010714785 | 7,500 | < 0.01 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 9,716,547 | 8,278,995 | 5,693,641 | 4,221,997 |
Annual Total Result | 5,451,000 | 5,590,030 | 2,211,277 | 3,637,098 |
Total assets | 7,833,851 | 9,378,876 | 7,071,087 | 6,499,051 |
Total liabilities | 2,352,851 | 2,651,095 | 1,933,336 | 2,822,577 |
Total equity | 5,481,000 | 6,727,781 | 5,137,751 | 3,676,474 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 9,716,547 | 8,278,995 | 5,693,641 | 4,221,997 |
Total operating costs | 1,203,892 | 833,560 | 2,043,784 | 30,538 |
Operating result | 8,512,655 | 7,445,435 | 3,649,857 | 4,191,460 |
Financial income/costs | -1,186,701 | -217,634 | -635,701 | 370,198 |
Profit before tax | 7,325,954 | 7,227,801 | 3,014,156 | 4,561,658 |
Total tax & extraordinary income/cost | 1,874,954 | 1,637,771 | 802,879 | 924,560 |
Annual Total Result | 5,451,000 | 5,590,030 | 2,211,277 | 3,637,098 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total fixed assets | 3,616,553 | 4,275,569 | 4,455,290 | 3,942,741 |
Total current assets | 4,217,298 | 5,103,307 | 2,615,797 | 2,556,310 |
Total assets | 7,833,851 | 9,378,876 | 7,071,087 | 6,499,051 |
Short term debt | 2,352,490 | 2,649,901 | 1,933,336 | 2,822,577 |
Long term debt | 0 | 1,194 | 0 | 0 |
Total liabilities | 2,352,851 | 2,651,095 | 1,933,336 | 2,822,577 |
Contributed capital | 30,000 | 30,000 | 30,000 | 30,000 |
Retained earnings | 5,451,000 | 6,697,781 | 5,107,751 | 3,646,474 |
Total equity | 5,481,000 | 6,727,781 | 5,137,751 | 3,676,474 |
Total equity and liabilities | 7,833,851 | 9,378,876 | 7,071,087 | 6,499,051 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company